Clinical Trials Browser

Neuroendocrine Tumors × entinostat × 30 days × Clear all

NCT03211988 2026-03-02

Entinostat Neuroendocrine (NE) Tumor

Phase 2 Terminated

5 enrolled 9 charts

Recurrence, Neuroendocrine Tumors